Long-acting injectable HIV therapy offers hope for those unable to take pills
|
But they only approved it for HIV patients who
already had their infections under control with pills. Researchers at UCSF
wanted to see if it would ... |
Gilead's lenacapavir applications for HIV gain EMA validation
Gilead's lenacapavir gained approval in several nations for treating the adult population with multi-drug resistant HIV in conjunction with other ... View article...